Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ni Ai

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|August 16, 2021
[Research progress on in vitro models of cardiomyocyte injury]Yan-Yi Li, Jun-Jun Li, Fu-Xing Ge, et al.
Phytochemistry|October 3, 2022
Discovery of steroidal alkaloid glycosides from the bulbs of Fritillaria unibracteata with anti-inflammatory activities using an in vivo zebrafish modelShu-Hui Wang, Yu-Qi Wang, Tian Lv, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 17, 2019
[TCM chemical biology--emerging interdiscipline of "TCM chemistry" and "biology"]Ke-Wu Zeng, Yong Jiang, Jing Wang, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|May 1, 2010
Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitroDeanna L Howarth, Lee R Hagey, Sheran H W Law, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulationYvonne S Lin, Kazuto Yasuda, Mahfoud Assem, et al.
Molecular Pharmacology|June 20, 2007
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sitesSean Ekins, Cheng Chang, Sridhar Mani, et al.
Nature Communications|October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomasPaul K Paik, Jia Luo, Ni Ai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|August 16, 2021
[Research progress on in vitro models of cardiomyocyte injury]Yan-Yi Li, Jun-Jun Li, Fu-Xing Ge, et al.
Phytochemistry|October 3, 2022
Discovery of steroidal alkaloid glycosides from the bulbs of Fritillaria unibracteata with anti-inflammatory activities using an in vivo zebrafish modelShu-Hui Wang, Yu-Qi Wang, Tian Lv, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 17, 2019
[TCM chemical biology--emerging interdiscipline of "TCM chemistry" and "biology"]Ke-Wu Zeng, Yong Jiang, Jing Wang, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|May 1, 2010
Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitroDeanna L Howarth, Lee R Hagey, Sheran H W Law, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulationYvonne S Lin, Kazuto Yasuda, Mahfoud Assem, et al.
Molecular Pharmacology|June 20, 2007
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sitesSean Ekins, Cheng Chang, Sridhar Mani, et al.
Nature Communications|October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomasPaul K Paik, Jia Luo, Ni Ai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Pageof 6